[{"NetIncomeLoss":329200000.0,"PropertyPlantAndEquipmentNet":3410700000.0,"DebtSecuritiesAvailableForSaleRealizedGain":100000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments":91200000.0,"ProceedsFromPaymentsForOtherFinancingActivities":-22900000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent":210700000.0,"DeferredIncomeTaxLiabilitiesNet":774700000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits":0.071,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":10881700000.0,"PaymentsToAcquireIntangibleAssets":1900000.0,"CashEquivalentsAtCarryingValue":978900000.0,"AdditionalPaidInCapital":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment":600000.0,"EquitySecuritiesFvNiRealizedGainLoss":2700000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":0.21,"IntangibleAssetsNetExcludingGoodwill":2286800000.0,"OtherAccruedLiabilitiesCurrent":713200000.0,"EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential":-0.202,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":1541800000.0,"InterestExpense":66300000.0,"NonoperatingIncomeExpense":-502900000.0,"AccountsPayableCurrent":427900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":254600000.0,"LiabilitiesCurrent":4211600000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue":1413400000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent":0.0,"WeightedAverageNumberOfSharesOutstandingBasic":148000000.0,"RepaymentsOfDebt":170000000.0,"InventoryRawMaterialsNetOfReserves":366000000.0,"NetCashProvidedByUsedInOperatingActivities":2801600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax":-47700000.0,"ValuationAllowancesAndReservesBalance":1128600000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation":8300000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment":28100000.0,"Goodwill":5760500000.0,"PaymentsForProceedsFromDerivativeInstrumentFinancingActivities":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax":1100000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent":35200000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":1944200000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":195000000.0,"IncomeLossFromEquityMethodInvestments":17200000.0,"DebtInstrumentFairValue":8046500000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":195000000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses":0.0,"EarningsPerShareDiluted":2.22,"AssetImpairmentCharges":0.0,"IncreaseDecreaseInAccountsReceivable":-157800000.0,"RetainedEarningsAccumulatedDeficit":13543500000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization":-0.062,"TaxesPayableCurrent":234200000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive":180000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis":2381500000.0,"PaymentsToAcquirePropertyPlantAndEquipment":206500000.0,"PaymentsToMinorityShareholders":94800000.0,"StockholdersEquity":10429900000.0,"ConstructionPayableCurrentAndNoncurrent":27700000.0,"OtherLiabilitiesCurrent":2550700000.0,"OtherLiabilitiesNoncurrent":1318200000.0,"ProfitLoss":1748100000.0,"DeferredTaxAssetsLiabilitiesNet":500000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear":70000000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes":0.003,"StockIssuedDuringPeriodValueTreasuryStockReissued":11000000.0,"AllocatedShareBasedCompensationExpense":-57600000.0,"EmployeeRelatedLiabilitiesCurrent":299200000.0,"LiabilitiesAndStockholdersEquity":23806700000.0,"DeferredIncomeTaxExpenseBenefit":-750100000.0,"PreferredStockValue":0.0,"InvestmentIncomeInterest":2600000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax":-1500000.0,"InventoryNet":1347900000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable":260500000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax":66200000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent":1413300000.0,"PaymentsForRepurchaseOfCommonStock":1800000000.0,"NotesPayableCurrent":998800000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments":291100000.0,"OperatingIncomeLoss":794000000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost":925500000.0,"NotesPayable":7271100000.0,"CommonStockParOrStatedValuePerShare":0.0005,"AccruedIncomeTaxesNoncurrent":657600000.0,"DeferredIncomeTaxAssetsNet":1810400000.0,"PreferredStockParOrStatedValuePerShare":0.001,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount":1900000.0,"OperatingLeaseRightOfUseAsset":389100000.0,"ShareBasedCompensation":179800000.0,"StockholdersEquityOther":0.0,"OtherComprehensiveIncomeLossNetOfTax":35200000.0,"Assets":23806700000.0,"AvailableForSaleSecuritiesDebtSecurities":2381600000.0,"InventoryWorkInProcessNetOfReserves":780800000.0,"EquitySecuritiesFvNi":1166200000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities":575400000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax":100000.0,"TreasuryStockValue":2977100000.0,"GoodwillImpairedAccumulatedImpairmentLoss":0.0,"ResearchAndDevelopmentInProcess":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised":-5000000.0,"AllocatedShareBasedCompensationExpenseNetOfTax":62100000.0,"CostOfGoodsAndServicesSold":511800000.0,"ProceedsFromIssuanceOfLongTermDebt":0.0,"SellingGeneralAndAdministrativeExpense":654100000.0,"IncreaseDecreaseInEquitySecuritiesFvNi":-710500000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt":2372600000.0,"OtherNoncashIncomeExpense":-201000000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax":63000000.0,"TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease":15100000.0,"LongTermDebt":6272300000.0,"AssetsCurrent":7162300000.0,"PaymentsForProceedsFromOtherInvestingActivities":-600000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax":1000000.0,"Depreciation":65100000.0,"NetCashProvidedByUsedInInvestingActivities":-451000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense":10900000.0,"EquitySecuritiesFvNiCost":1168900000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax":-136600000.0,"InventoryFinishedGoodsNetOfReserves":201100000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest":-11100000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax":99400000.0,"CommitmentsAndContingencies":null,"RepaymentsOfLongTermDebt":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":210000000.0,"AccruedRoyaltiesCurrent":238900000.0,"EquitySecuritiesFvNiGainLoss":-424200000.0,"NetIncomeLossAttributableToNoncontrollingInterest":-11100000.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments":0.012,"IncreaseDecreaseInOtherOperatingCapitalNet":87600000.0,"Liabilities":12925000000.0,"DebtSecuritiesAvailableForSaleRealizedLoss":500000.0,"OperatingLeaseLiabilityNoncurrent":348200000.0,"OtherAssetsNoncurrent":2018600000.0,"ComprehensiveIncomeNetOfTax":364400000.0,"GoodwillOtherIncreaseDecrease":-1600000.0,"IncreaseDecreaseInInventories":322600000.0,"OtherAssetsCurrent":736300000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities":2028100000.0,"CostsAndExpenses":1984900000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill":629300000.0,"RealizedInvestmentGainsLosses":-424500000.0,"NetCashProvidedByUsedInFinancingActivities":-2096000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost":702400000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost":1413300000.0,"EffectiveIncomeTaxRateContinuingOperations":-0.089,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings":15600000.0,"ForeignCurrencyTransactionGainLossBeforeTax":-13700000.0,"IntangibleAssetsGrossExcludingGoodwill":7607200000.0,"PaymentsToAcquireInProcessResearchAndDevelopment":18000000.0,"DepreciationDepletionAndAmortization":353000000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue":925300000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent":968300000.0,"Revenues":2778900000.0,"EffectOfExchangeRateOnCashAndCashEquivalents":-44000000.0,"CommonStockValue":100000.0,"NumberOfReportableSegments":1.0,"IncomeTaxExpenseBenefit":-25900000.0,"AccountsReceivableNetCurrent":1723000000.0,"OtherNonoperatingIncomeExpense":-1000000.0,"IncreaseDecreaseInAccruedLiabilities":-243300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding":150300000.0,"PaymentsOfFinancingCosts":24400000.0,"EquitySecuritiesFvNiUnrealizedGainLoss":-426900000.0,"MinorityInterest":451800000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths":255000000.0,"EarningsPerShareBasic":2.22,"FiniteLivedIntangibleAssetsAccumulatedAmortization":5320400000.0,"IncreaseDecreaseInDueFromRelatedParties":-13500000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments":-13500000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest":353300000.0,"AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears":70800000.0,"AmortizationAndImpairmentOfAcquiredIntangibleAssets":111000000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost":42800000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue":42800000.0,"Collaborationexpensesaccrual":289300000.0,"Collaborationprofitlosssharing":21200000.0,"CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear":2823200000.0,"DuefromantiCD20therapeuticprograms":400000000.0,"EffectiveTaxRateReconciliationGILTItax":0.026,"EffectiveTaxRateReconciliationNuerImmuneTaxImpacts":-0.005,"EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax":257900000.0,"EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax":260600000.0,"IncomeLossFromEquityMethodInvestmentsNetOfTax":1100000.0,"InterestInSubsidiary":1.0,"Inventorynetcurrentandnoncurrent":1347900000.0,"InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities":17200000.0,"NoncontrollingInterestCapitalContribution":0.0,"NoncontrollingInterestIncreaseDecreaseOther":0.0,"NumberOfWholesalers":2.0,"PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear":2021100000.0,"PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear":878700000.0,"ShareBasedCompensationExpenseIncludedInCostsAndExpenses":60200000.0,"TechnologicalAndRegulatorySuccessProbability":0.108,"UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax":21900000.0,"UnrealizedGrossGainsOnForeignCurrencyDerivativesNetBeforeTax":16500000.0,"UnrealizedGrossLossesOnForeignCurrencyDerivativesNetBeforeTax":38400000.0,"ddate":20210930,"qtrs":1,"uom":"USD","footnote":null,"form":"10-Q","period":20210930.0,"fy":2021.0,"fp":"Q3","Symbol":"BIIB","GICS Sector":"Health Care","GICS Sub-Industry":"Biotechnology"}]